PATHOLOGIEDATENERFASSUNG

Patent europeic · EP3491558 · En vigur

Inscripziun en il register

Numer da publicaziun
EP3491558
Numer da la dumonda
EP17749337
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
En vigur
Scrittira da patent
Concedì
Annunzià
28-07-2017
Publitgà
05-06-2019
Concedì
15-10-2025
La protecziun finescha il pli tard
27-07-2037
Proxima taxa annuala scadenta
31-07-2026
Classas IPC
G16H 30/40 (2018.01)
G16H 30/20 (2018.01)
G16H 10/40 (2018.01)
G02B 21/36 (2006.01)
G02B 27/00 (2006.01)
Prioritad
US 201615225247 01.08.2016
Dumonda PCT
PCT/US2017/044541 28.07.2017
Publicaziun PCT
WO2018/026666 08.02.2018
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 26-08-2026

    Midada

    Published in Swissreg on 26.08.2026

  2. 23-04-2026

    Owner

    Owner
    Verily Life Sciences LLC, 2999 Olympus Blvd, 10th Floor / Ste 1000, Dallas, TX 75019, USA → Verily Health Inc., 2999 Olympus Blvd, 10th Floor, Ste 1000, Dallas, Texas 75019, USA

    Published in Swissreg on 23.04.2026

  3. 15-10-2025

    Concedì

    Specification status
    Non-published patent application → Granted patent
    Status of protective title
    Initiated → Active

    Published in Swissreg on 15.10.2025

Partidas

Possessur

Verily Health Inc.

2999 Olympus Blvd 10th Floor, Ste 1000, Dallas, Texas 75019, US

Inventur

BARRAL, Joëlle K.

Mountain View, California 94043, US

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.